MedPath

Assessment of the Efficacy and Barrier Protection of Two Cosmetic Products

Not Applicable
Completed
Conditions
Aged Skin
Interventions
Other: C - pH 4 Cosmetic Product WO 3741
Other: D - pH 5.8 Cosmetic Product WO 4081-1
Registration Number
NCT03629405
Lead Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Brief Summary

The aim of the study was to assess the long-term efficacy and barrier protection properties of two cosmetic products on the volar forearms of 20 elderly subjects after four weeks of treatment compared to two untreated test areas.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Written Informed Consent to participate in the study
  • Willingness to actively participate in the study and to come to the scheduled visits
  • Female and male (at least 30% male subjects)
  • From 50 to 75 years of age, equally distributed
Exclusion Criteria
  • Female subjects: Pregnancy or lactation
  • Drug addicts, alcoholics
  • AIDS or infectious hepatitis if known to the subjects
  • Conditions which exclude a participation or might influence the test reaction/ evaluation
  • Participation or being in the waiting period after participation in similar cosmetic and/or pharmaceutical studies
  • Active skin disease at the test area
  • One of the following serious illnesses that might require regular systemic medication: insulin-dependent diabetes
  • Moles, tattoos, scars, irritated skin, hairs, etc. at the test area that could influence the Investigation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
C - Cosmetic Product WO 3741 with pH 4C - pH 4 Cosmetic Product WO 3741On the forearms four test areas were located, which were labeled from A-D. Test area C on the same arm like product D.
D - Cosmetic Product WO 4081-1 with pH 5.8D - pH 5.8 Cosmetic Product WO 4081-1On the forearms four test areas were located, which were labeled from A-D.
Primary Outcome Measures
NameTimeMethod
Skin pHbaseline, Day 29, Day 30

Change from baseline at Day 29 and Day 30 of Skin pH Units assessed by pH-meter

Secondary Outcome Measures
NameTimeMethod
Transepidermal Water Lossbaseline, Day 29, Day 30

Change from baseline at Day 29 and Day 30 of Transepidermal Water Loss (g/m2/h) assessed by Tewameter

Lipid Analysis ((concentration of : Cholesterol (µg/slide), FFA (µg/slide), Ceramide EOS (µg/slide), Ceramide NP (µg/slide), Ceramide NH (µg/slide))baseline, Day 29, Day 30

Change from baseline at Day 29 and Day 30 of corneocyte layer area assessed from the TEM data

Skin Hydrationbaseline, Day 29, Day 30

Change from baseline at Day 29 and Day 30 of Skin Hydration Arbitrary Units assessed by Corneometer

Intercellular lipid lamellae lenght (nm ICLL/1000 nm2 ICS)baseline, Day 29, Day 30

Change from baseline at Day 29 and Day 30 of stratum corneum assessed by transmission electron microscopy

Trial Locations

Locations (1)

proDERM Institute for Applied Dermatological Research

🇩🇪

Schenefeld, Germany

© Copyright 2025. All Rights Reserved by MedPath